Alzheimer's disease (AD), the most common cause of dementia in the elderly population, is
closely linked to a dysregulated cerebral lipid homeostasis and particular changes in brain …

Cerebral clearance of amyloid β‐protein (Aβ) is decreased in early‐onset and late‐onset
Alzheimer's disease (AD). Aβ is cleared from the brain by enzymatic degradation and by …

Oxidative stress is closely linked to Alzheimer's disease (AD), and is detected peripherally
as well as in AD-vulnerable brain regions. Oxidative stress results from an imbalance …

Background Alzheimer's disease is a significant public health issue. Recent studies have
shown that the gut microbiota plays a vital role in the onset and development of Alzheimer's …

Alzheimer's disease (AD) is the most common cause of dementia, characterized by a
spectrum of symptoms associated with memory loss and cognitive decline with deleterious …

The deterioration of brain glucose metabolism predates the clinical onset of Alzheimer's
disease (AD). Medium-chain triglycerides (MCTs) and docosahexaenoic acid (DHA) …

We read with interest the article by Carrera-Juliá et al.(1) including analyses of the effects on
anthropometric outcomes of a Mediterranean diet (MeDi)—with a carbohydrate target at …

Alzheimer's disease (AD) is characterized by an increased plaque burden and tangle
accumulation in the brain accompanied by extensive lipid alterations. Methylxanthines …

Alzheimer's disease is one of the most common neurodegenerative diseases in the western
population. The incidence of this disease increases with age. Rising life expectancy and the …

Insulin-degrading enzyme (IDE) is an evolutionarily conserved ubiquitous zinc
metalloprotease implicated in the efficient degradation of insulin monomer. However, IDE …